PPI Use in Type 2 Diabetes Links With Cardiovascular Events PPI Use in Type 2 Diabetes Links With Cardiovascular Events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more cardiovascular disease events and all-cause death than nonuse.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Proton Pump Inhibitors PPIs